Research and Training Funding

Funding Opportunity Announcements

Browse below for Data Science Funding Opportunity Announcements.

This page last reviewed on August 7, 2019

Feed last updated: December 06 2019 1:51 am
Title FOA Number Organization Release Date Expiration Date Purpose Search Terms
Limited Competition: NIGMS National and Regional Resources (R24 - Clinical Trial Not Allowed) PAR-19-301 NIGMS Jun 24 2019 Jun 16 2021 This Funding Opportunity Announcement (FOA) encourages applications for support of national or regional resources that will provide access to state-of-the-art facilities, equipment, technologies, research tools, software, and/or service to a substantial user base at institutions across multiple states (regional) or the country (national). These resources should already be established, although new resources formed through consolidation of multiple local or regional facilities are also eligible. They should be poised to achieve or already have achieved significant economies of scale and should be able to significantly increase access to the supported technologies or services for researchers across one or more regions or the country. Major new research and development efforts should not be included. For this FOA, a resource is defined as an activity that provides research capabilities and expertise to a large number of investigators and is available to any qualified investigator as a service. The intent is to provide access to investigators without regard to the particular biomedical focus of their research, but not to duplicate or replace resources supported by other NIH Institutes and Centers (ICs) or host institutions. Only those resources whose technical capabilities fall within the program areas supported by NIGMS will be supported. It is expected that the resource will be maintained or upgraded to current best practices, make its capability and availability known to the biomedical research community through outreach activities, and provide user training and support. Stand-alone data resources and databases are not eligible for funding through this FOA. This FOA is limited to applications requesting support for resources that have been developed through previous NIGMS funding.
Investigator Initiated Research in Computational Genomics and Data Science (R43/R44 Clinical Trial Not Allowed) PAR-19-061 NHGRI Nov 08 2018 Sep 06 2021 The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research efforts aimed towards commercial product development in computational genomics, data science, statistics, and bioinformatics relevant to one or both of basic or clinical genomic science, and broadly applicable to human health and disease. This FOA supports genomics research developing innovative analytical and computational commercial products, methodologies, and approaches, early stage development of commercial tools and software, and refinement or hardening of software and tools of high value to the biomedical genomics community. Work supported under this FOA should be enabling for genomics and be generalizable or broadly applicable across diseases and biological systems. data science, computational, bioinformatics, statistics
Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed) PAR-18-843 NHGRI Jun 28 2018 Sep 08 2021 The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research efforts in computational genomics, data science, statistics, and bioinformatics relevant to one or both of basic or clinical genomic science, and broadly applicable to human health and disease. This FOA supports fundamental genomics research developing innovative analytical methodologies and approaches, early stage development of tools and software, and refinement or hardening of software and tools of high value to the biomedical genomics community. Work supported under this FOA should be enabling for genomics and be generalizable or broadly applicable across diseases and biological systems. All proposals should address how the methods would scale to address larger and larger data sets. data science, computational, bioinformatics, statistics
Investigator Initiated Research in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed) PAR-18-844 NHGRI Jun 28 2018 Sep 08 2021 The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research efforts in computational genomics, data science, statistics, and bioinformatics relevant to one or both of basic or clinical genomic science, and broadly applicable to human health and disease. This FOA supports fundamental genomics research developing innovative analytical methodologies and approaches, early stage development of tools and software, and refinement or hardening of software and tools of high value to the biomedical genomics community. Work supported under this FOA should be enabling for genomics and be generalizable or broadly applicable across diseases and biological systems. All proposals should address how the methods would scale to address larger and larger data sets. data science, computational, bioinformatics, statistics
Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (R01) PAR-17-033 NIA Oct 25 2016 May 08 2020 This FOA invites applications that apply a cross-disciplinary, team science approach to gain comprehensive, mechanistic understanding of the impact of sex differences on the trajectories of brain aging and phenotypes of AD risk and on the responsiveness to pharmacologic and non-pharmacologic interventions.
Institutional Training Programs to Advance Translational Research on Alzheimer's Disease and AD Related Dementias (T32 - Clinical Trial Not Allowed) PAR-18-524 NIA Dec 21 2017 Jan 08 2021 This Funding Opportunity Announcement (FOA) seeks to enable the development of a diverse, translational research workforce capable of participating and/or leading cross-disciplinary team science programs focused on advancing therapy development for Alzheimer's disease (AD) and AD-related dementias. This FOA will support institutional training programs for predoctoral and postdoctoral level researchers with diverse educational backgrounds (i.e. basic biology, translational and clinical research, data science). The program invites eligible institutions to develop interdisciplinary training programs that will provide trainees with the knowledge and skills in data science, disease biology, and traditional and emerging drug discovery disciplines necessary to conduct rigorous and cutting-edge basic, translational and clinical research for AD and AD-related dementias. data science
Institutional Training for a Dental, Oral and Craniofacial Research Workforce (T90/R90 Clinical Trial Not Allowed) PAR-20-056 NIDCR Nov 20 2019 Sep 27 2022 The National Institute of Dental and Craniofacial Research (NIDCR) will award T90/R90 grants to eligible, domestic institutions to enhance predoctoral and postdoctoral research training (T90) and postdoctoral research education (R90) to ensure that a diverse and highly qualified workforce is available to address the Nations basic and clinical biomedical and behavioral or social sciences research agenda. Research training programs will incorporate didactic, research, and career development components to prepare individuals for careers as independent scientists that will have a significant impact on the dental, oral, and craniofacial health-related research needs of the Nation. This Funding Opportunity Announcement (FOA) does not allow appointed trainees to lead an independent clinical trial, but does allow them to obtain research experience in a clinical trial led by a mentor or co-mentor.
Initiative to Maximize Research Education in Genomics: Diversity Action Plan (R25) PAR-19-380 NHGRI Sep 17 2019 Sep 26 2022 The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this NHGRI R25 program is to support educational activities that The overarching goal of this NHGRI R25 program is to support educational activities that enhance the diversity of the biomedical, behavioral and clinical research workforce in genomics. This funding opportunity announcement seeks to expose underrepresented students at the undergraduate, post-baccalaureate and graduate levels to the foundational sciences relevant to genomics to enable them to pursue careers that span all areas of interest to NHGRI - genome sciences, genomic medicine and genomics and society. For the purposes of this FOA, the term genomics encompasses issues and activities in these three areas of genomic research.
Improving Individual and Family Outcomes through Continuity and Coordination of Care in Hospice (R21 Clinical Trial Optional) PA-18-166 NINR Nov 07 2017 Jan 08 2020 This funding opportunity announcement (FOA) seeks to stimulate research that focuses on reducing negative individual and family outcomes related to unwanted transitions at the end of life and optimizing the individual and family outcomes related to high quality coordination of care of care of individuals who are enrolled in hospice. This FOA emphasizes individuals who are receiving hospice care and their family caregivers, in any setting where hospice care is provided, including their home, a relatives home, a hospice inpatient facility, an assisted living facility, a short- or long-term care facility, or a hospital.
Improving Individual and Family Outcomes through Continuity and Coordination of Care in Hospice (R01 Clinical Trial Optional) PA-18-148 NINR Nov 07 2017 Jan 08 2020 This funding opportunity announcement (FOA) seeks to stimulate research that focuses on reducing negative individual and family outcomes related to unwanted transitions at the end of life and optimizing the individual and family outcomes related to high quality coordination of care of care of individuals who are enrolled in hospice. This FOA emphasizes individuals who are receiving hospice care and their family caregivers, in any setting where hospice care is provided, including their home, a relatives home, a hospice inpatient facility, an assisted living facility, a short- or long-term care facility, or a hospital.

Pages

XLS